Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Subtypes of lung adenocarcinomas associated with IPF

Georgia Gomatou, Rodoula Tringidou, Thodoris Karampitsakos, Vasilios Tzilas, Argyrios Tzouvelekis, Demosthenes Bouros
European Respiratory Journal 2019 54: PA1310; DOI: 10.1183/13993003.congress-2019.PA1310
Georgia Gomatou
1Interstitial Lung Diseases Unit, Medical School, National and Kapodistrian University of Athens, and Hospital for Diseases of the CHEST “SOTIRIA”, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: georgia.gomatou@gmail.com
Rodoula Tringidou
2Department of Pathology, Hospital for Diseases of the CHEST “SOTIRIA”, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thodoris Karampitsakos
1Interstitial Lung Diseases Unit, Medical School, National and Kapodistrian University of Athens, and Hospital for Diseases of the CHEST “SOTIRIA”, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vasilios Tzilas
1Interstitial Lung Diseases Unit, Medical School, National and Kapodistrian University of Athens, and Hospital for Diseases of the CHEST “SOTIRIA”, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Argyrios Tzouvelekis
1Interstitial Lung Diseases Unit, Medical School, National and Kapodistrian University of Athens, and Hospital for Diseases of the CHEST “SOTIRIA”, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Demosthenes Bouros
1Interstitial Lung Diseases Unit, Medical School, National and Kapodistrian University of Athens, and Hospital for Diseases of the CHEST “SOTIRIA”, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Background: Epidemiological data supports a strong correlation between Idiopathic Pulmonary Fibrosis (IPF) and lung cancer. Data regarding adenocarcinoma (ADC) histological subtypes in IPF patients is limited.

Aim: To describe the subtypes of IPF-associated ADC.

Patients and Methods: This was a unicentric retrospective study. We identified 45 cases with IPF and lung cancer among 360 in total with IPF between 2009-2018. Most cases (77.7%, n=35) were non-small cell lung cancer (16 squamous, 11 ADC, 2 adenosquamous, 1 sarcomatoid, 5 non-specified). In 8 ADC cases data was available for further characterization (Group A). Data was compared with data derived from a historical cohort.

Results: Baseline characteristics of patients (Group A) were: mean age±SD=71.1±8.1, 8 males, meanFVC±SD= 84±16.6, meanDLCO±SD= 63±11.9. Median survival was 24.5 months. Subtypes were: lepidic=2, solid=2, acinar=1, minimally invasive ADC=1, fetal=1, ADC with enteric features=1 (Table 1). Statistical comparison to a historical cohort of 500 ADCs from our center revealed: higher frequency of enteric and fetal subtypes among IPF-ADC (enteric: 9.1%vs0.2%, fetal: 9.1%vs0.2%) and lower frequency (9.1%vs41.4%) of acinar subtype (p<0.05).

Conclusions: Different distribution of histologic subtypes among IPF-ADC indicates a potentially distinct origin and pathogenesis compared to non-IPF-ADC.

View this table:
  • View inline
  • View popup

  • Lung cancer
  • Idiopathic pulmonary fibrosis

Footnotes

Cite this article as: European Respiratory Journal 2019; 54: Suppl. 63, PA1310.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2019
Previous
Back to top
Vol 54 Issue suppl 63 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Subtypes of lung adenocarcinomas associated with IPF
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Subtypes of lung adenocarcinomas associated with IPF
Georgia Gomatou, Rodoula Tringidou, Thodoris Karampitsakos, Vasilios Tzilas, Argyrios Tzouvelekis, Demosthenes Bouros
European Respiratory Journal Sep 2019, 54 (suppl 63) PA1310; DOI: 10.1183/13993003.congress-2019.PA1310

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Subtypes of lung adenocarcinomas associated with IPF
Georgia Gomatou, Rodoula Tringidou, Thodoris Karampitsakos, Vasilios Tzilas, Argyrios Tzouvelekis, Demosthenes Bouros
European Respiratory Journal Sep 2019, 54 (suppl 63) PA1310; DOI: 10.1183/13993003.congress-2019.PA1310
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT
  • Late Breaking Abstract - Phase 2 trial evaluating the effects of dexpramipexole on blood eosinophils, lung function, and airway biomarkers in eosinophilic asthma
  • All-cause mortality in an Idiopathic Pulmonary Fibrosis (IPF) cohort: retrospective analysis with cardiac QRISK-2
Show more Idiopathic interstitial pneumonias

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society